PROBLEM: The COVID-19 has demonstrated the need to break through data silos, especially among diabetes patients. Several studies suggest that 30-40% of all COVID-19 deaths occurred among people with diabetes, highlighting a grim public health problem made worse. Already, diabetes is the most expensive chronic condition in our nation. Although the 2009 Health Information Technology for Economic and Clinical Health Act required organizations to adopt electronic healthcare records (EHR), there remain significant barriers to the interchange of healthcare data due to policies that don’t require organizations to bridge the gap in data sharing. EHR vendors have lobbied and opposed legislation that would make standardized healthcare data sharing difficult. Thus, with cross-institutional data sharing made difficult, stakeholders like healthcare providers treating the patient often have fragmented data (i.e. lack of information on how high a patient’s risk actually is based on actual high and low glucose data from the patient) and thus obfuscate opportunities for timely treatment and/or interventions needed.
SOLUTION: This is where a blockchain-based platform can make a difference in diabetes. Factors like the rapid advancement of continuous glucose monitors (covered by Medicare, Medicaid, and most insurers) and the large generation of data specifically related to diabetes and their overall health give the application of a blockchain-based platform even more promise. This platform would use multi-signature blockchain contracts that give the patient control of data management and healthcare information sharing. This multi-signature contract would assign the rights and powers of one account to others and could be easily edited to allow or remove entities. With this approach, diabetes patients could more efficiently share data between institutions while giving them privacy and control of their healthcare data.
Capital contribution of each founder:
The founders agree to split all costs equally with AR/Cash as required for the development and maintenance of the platform and protection of company resources from the time of this agreement. No founder is required to make an initial capital contribution.
Percentage of shares to be held by each founder:
The founders agree to an equal split of any shares, units, or other methods of ownership assignment.
Remuneration of Founders:
The founders agree to no remuneration until after a series A round of funding, acquisition, or until this agreement is replaced via incorporation.
Role of each founder:
Ideatrek will be responsible for all institutional backend, operational, and reporting responsibilities
Yoona shin // 1401 Mason Farm Rd, Chapel Hill, NC 27514, USA //
Whether the founders are restricted from competing with the business of the company after they exit:
The founders may work on other businesses during the life of the company until otherwise required by future agreements. However, the founders are not allowed to share company secrets, technology, or intellectual property with other ventures unless permitted by the other founders in writing.
How the company’s confidential information and intellectual property will be protected:
No founder shall share, sell or otherwise disseminate any information regarding company business with any outside party for the life of the company until a future agreement is reached.
Tue Apr 19 2022 // Yoona shin is now EPE. // undefined // $undefined